AVTR Avantor, Inc. Common Stock
NYSE · Life Sciences Tools & Services · SEC EDGAR'da Görüntüle ↗ kapat Eki 5, 2026 10-K/10-Q Tem 29, 2026
$15,81
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$7,2752 haftanın en düşüğü
$16,0552 haftanın en yükseği
Piyasa Değeri
$10.78B
P/E (TTM)
-18.8
Hisse Başına Kâr (TTM)
$-0.84
Gelir (TTM)
$6.56B
rozetleriniz
52 Haftlık Aralık
$7–$16
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
$15
P/E
-18.8
ROE
-9.7%
Net Kâr Marjı
-8.8%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
AVTR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$15.81
Piyasa Değeri
$10.78B
P/E (TTM)
-18.8
Hisse Başına Kâr (TTM)
$-0.84
Gelir (TTM)
$6.56B
ROE (TTM)
-9.7%
D/E Borç/Özsermaye (MRQ)
0.7
52 Haftlık Aralık
$7–$16
AVTR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Avantor, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.
History
The company's history traces back to 1904, when John Townsend Baker (1860–1935) founded the chemical company J.T. Baker specializing in producing chemically pure reagents. The company gained recognition for its "Baker Analyzed" labels, which provided detailed analyses of trace impurities in its products. In 1911, the company began publishing "The Chemist-Analyst," which promoted its products and philosophy. After Baker's death in 1935, the company was acquired by Vick Chemical Company in 1941. During World War II, J.T. Baker expanded its product line to include penicillin, pesticides, and chemicals for batteries and munitions. After the war, the company further diversified into high-purity solvents, chromatography columns, and hazardous waste spill kits. In 1985, J.T. Baker and its parent company Richardson-Vicks were sold to Procter & Gamble, and subsequently sold to Mallinckrodt in 1995.
In 2010, investment firm New Mountain Capital purchased Mallinckrodt Baker Inc., which then changed its name to Avantor. The company extended its international market with the 2011 acquisitions of the Indian laboratory reagents supplier RFCL and the Polish lab supply firm POCH.
In 2016, Avantor merged with Nusil Technology. In 2017, Avantor acquired chemical blending business Puritan Products Inc. and laboratory supplies company VWR. The combined company operates under the Avantor name, with VWR and vwr.com remaining as a selling channel.
In May 2019, Avantor went public with a $3.8 billion initial public offering, which gave the company a market capitalization of $7.62 billion. As of December 2023, the top shareholders of Avantor included Vanguard Group Inc., Dodge & Cox Inc., T. Rowe Price Investment Management Inc., and BlackRock Inc.
That same year the company expanded further into Asia with the opening of an innovation center in Shanghai, which focuses on monoclonal antibodies and cell and gene therapy. In 2020, Avantor doubled the size of its Bridgewater, New Jersey innovation center, expanding its research and development capabilities and cell and gene therapy reagent manufacturing.
In 2020, Avantor began providing services and raw materials to companies manufacturing vaccines and other therapies to fight the COVID-19 pandemic. Avantor added employees and extra shifts in order to increase capacity for producing synthetic lipids that are formed into nanoparticles, which carry mRNA into human cells.
In June 2021, Avantor acquired China-based RIM Bio, a manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.
Through the acquisition, Avantor gained access to RIM's Changzhou, China facility, marking Avantor's first single-use production plant in the Africa, Middle East, Asia (AMEA) region. The deal is part of a larger expansion of the company's single-use manufacturing footprint with plans to increase its presence by 30%.
The company ranked 485th in 2023 and 506 in 2024 on the Fortune 500, based on its sales records.
Controversies
On August 26, 2020, Bloomberg News implicated Avantor and other companies in the U.S. opioid epidemic. According to Bloomberg, one of their compounds "acetic anhydride", was used illicitly by drug traffickers to convert crude opium into heroin. Bloomberg also found evidence that Avantor's compound was used in cartel drug labs, and that regulations implemented in 2018 didn't stop it from being widely available. In response, Avantor discontinued all sales of acetic anhydride in Mexico and destroyed its existing inventory. In 2021, Texas Senator John Cornyn, who serves on both the Judiciary Committee and the bipartisan Caucus on International Narcotics Control claims that Avantor should have known better, selling acetic anhydride within Mexico's unregulated market. What should have raised eyebrows as well is that it was sold in 18-liter containers, which is inconsistent with the ordinary use of acetic anhydride. Four other Republican senators also deplored Avantor's “apparent longstanding contribution to the opioid epidemic that killed 50,000 of our fellow citizens in 2019.”
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
sektörHealthcare
endüstriLife Sciences Tools & Services
çalışanlar13.500
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$6.55B2017-12-31 → 2025-12-31
Hisse Başına Kâr$-0.782018-12-31 → 2025-12-31
Serbest Nakit Akışı$495M2019-12-31 → 2025-12-31
Net kar marjı-8.8%2019-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | AVTR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -18.85Y ort. ≈24.9 | ≈24.9 | · | · | |
| P/S (F/S) | 1.65Y ort. ≈2.2 | ≈2.2 | 3.7 | Düşük değerli | |
| P/B (F/D) | 1.95Y ort. ≈3.2 | ≈3.2 | 3.6 | Düşük değerli | |
| EV / EBITDA | -58.35Y ort. ≈10.3 | ≈10.3 | · | · | |
| Price / FCF (Fiyat / Serbest Nakit Akışı) | 21.85Y ort. ≈21.7 | ≈21.7 | · | · | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | 17.35Y ort. ≈18.2 | ≈18.2 | 25.2 | Düşük değerli | |
| EV / Revenue (EV / Gelir) | 2.25Y ort. ≈2.9 | ≈2.9 | · | · | |
| EV / FCF | 29.05Y ort. ≈28.9 | ≈28.9 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | AVTR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 31.8%5Y ort. ≈33.7% | ≈33.7% | 54.2% | Zayıf | |
| Faaliyet Kâr Marjı (TTM) | -4.6%5Y ort. ≈10.1% | ≈10.1% | 9.2% | Ortalamanın altında | |
| EBITDA Margin (FAVÖK Marjı) | -3.8%5Y ort. ≈10.1% | ≈10.1% | 8.3% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | -7.2%5Y ort. ≈6.7% | ≈6.7% | 5.9% | Ortalamanın altında | |
| Net Kâr Marjı (TTM) | -8.8%5Y ort. ≈4.8% | ≈4.8% | 2.4% | Aynı seviyede | |
| ROA (TTM) | -4.7%5Y ort. ≈2.7% | ≈2.7% | -0.14% | Zayıf | |
| ROE (TTM) | -9.7%5Y ort. ≈7.6% | ≈7.6% | -0.40% | Zayıf | |
| ROIC | -3.1%5Y ort. ≈5.1% | ≈5.1% | 1.1% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | AVTR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.75Y ort. ≈1.1 | ≈1.1 | 0.7 | Aynı seviyede | |
| Cari Oran (MRQ) | 1.85Y ort. ≈1.6 | ≈1.6 | 3.0 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 1.05Y ort. ≈0.9 | ≈0.9 | 1.6 | Ortalamanın altında | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 0.75Y ort. ≈1.0 | ≈1.0 | 0.7 | Aynı seviyede |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | AVTR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -3.4%5Y ort. ≈0.78% | ≈0.78% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -4.5%5Y ort. ≈-1.4% | ≈-1.4% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 0.49% | · | · | · | |
| EPS YoY (EPS YB) | 121.3%5Y ort. ≈232.8% | ≈232.8% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | 121.6%5Y ort. ≈119.8% | ≈119.8% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | 7.0% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | 7.5% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | AVTR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.55Y ort. ≈0.6 | ≈0.6 | 0.5 | Aynı seviyede | |
| Inventory Turnover (Stok Devir Hızı) | 5.75Y ort. ≈5.7 | ≈5.7 | 2.5 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 6.25Y ort. ≈6.2 | ≈6.2 | 5.7 | En üst düzey | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$485.3K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.49%
Sonraki Rapor
Eki 27, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Tem 30, 2026 | $0.21 | $0.19 | 8.6% |
| 31 Mart 2026 | $0.17 | $0.16 | 6.2% | |
| 31 Aralık 2025 | $0.22 | $0.22 | -0.36% | |
| 30 Eylül 2025 | $0.22 | $0.23 | -4.0% | |
| 30 Haziran 2025 | $0.24 | $0.25 | -5.1% | |
| 31 Mart 2025 | $0.23 | $0.24 | -2.4% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B | $6.39B | $6.04B | $5.86B | $1.25B | |
| Cost of Revenue | $4.41B | $4.50B | $4.60B | $4.91B | $4.88B | $4.31B | $4.12B | $4.04B | $815M | |
| Gross Profit | $2.14B | $2.28B | $2.36B | $2.60B | $2.50B | $2.08B | $1.92B | $1.82B | $433M | |
| SG&A Expense | $1.60B | $1.64B | $1.51B | $1.47B | $1.53B | $1.37B | $1.37B | $1.41B | $450M | |
| Operating Income | $-246M | $1.08B | $696M | $1.13B | $972M | $707M | $552M | $414M | $-210M | |
| Interest Expense | · | · | $285M | $266M | $217M | $308M | $440M | $524M | $201M | |
| Interest Income | $42M | $75M | $65M | $16M | $2M | · | · | · | · | |
| Other Non-op | $-21M | $-1M | $6M | $-800.0K | $11M | $10M | $2M | $-4M | $8M | |
| Pretax Income | $-441M | $854M | $410M | $851M | $753M | $62M | $41M | $-114M | $-460M | |
| Income Tax | $89M | $142M | $89M | $165M | $180M | $-54M | $3M | $-27M | $-315M | |
| Net Income | $-530M | $712M | $321M | $686M | $573M | $117M | $38M | $-87M | $-113M | |
| EPS (Basic) | $-0.78 | $1.05 | $0.48 | $1.02 | $0.86 | $0.09 | $-0.84 | $-2.69 | · | |
| EPS (Diluted) | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 | $0.09 | $-0.84 | $-2.69 | · | |
| Shares (Basic) | 680,600,000 | 679,600,000 | 675,600,000 | 650,900,000 | 590,500,000 | 576,300,000 | 401,200,000 | 132,700,000 | · | |
| Shares (Diluted) | 680,600,000 | 681,900,000 | 678,400,000 | 679,400,000 | 599,600,000 | 583,400,000 | 401,200,000 | 132,700,000 | · | |
| EBITDA | $-246M | $1.08B | $696M | $1.13B | $972M | $707M | $552M | · | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $365M | $262M | $263M | $373M | $302M | $287M | $187M | $185M | · | |
| Receivables | $1.07B | $1.03B | $1.15B | $1.22B | $1.22B | $1.11B | $989M | $931M | · | |
| Inventory | $818M | $732M | $828M | $914M | $872M | $740M | $711M | $671M | · | |
| Other Current Assets | $193M | $119M | $144M | $153M | $81M | $91M | $135M | $113M | · | |
| Current Assets | $2.45B | $2.15B | $2.38B | $2.66B | $2.48B | $2.23B | $2.02B | $1.90B | · | |
| PP&E (Net) | $767M | $708M | $738M | $727M | $706M | $550M | $557M | $599M | · | |
| PP&E (Gross) | $1.51B | $1.34B | $1.35B | $1.25B | $1.15B | $938M | $865M | $824M | · | |
| Accum. Depreciation | $745M | $630M | $617M | $518M | $445M | $388M | $308M | $226M | · | |
| Goodwill | $4.99B | $5.54B | $5.72B | $5.65B | $5.34B | $2.86B | $2.77B | $2.78B | $2.85B | |
| Intangibles | $3.10B | $3.27B | $3.68B | $4.04B | $5.05B | $3.96B | $4.13B | $4.47B | · | |
| Other Non-current Assets | $396M | $360M | $358M | $294M | $233M | $217M | $205M | $63M | · | |
| Total Assets | $11.79B | $12.11B | $12.97B | $13.46B | $13.90B | $9.91B | $9.77B | $9.91B | · | |
| Accounts Payable | $742M | $663M | $626M | $758M | $755M | $679M | $560M | $557M | · | |
| Current Liabilities | $1.38B | $2.01B | $1.48B | $1.66B | $1.45B | $1.24B | $1.07B | $1.10B | · | |
| Capital Leases | $152M | $143M | $88M | $87M | $79M | · | $107M | · | · | |
| Deferred Tax | $557M | $557M | $613M | $731M | $913M | $724M | $785M | $908M | · | |
| Other Non-current Liabilities | $378M | $358M | $350M | $295M | $358M | $398M | $428M | $318M | · | |
| Total Liabilities | $6.23B | $6.16B | $7.72B | $8.61B | $9.70B | $7.23B | $7.31B | $9.10B | · | |
| Long-term Debt | $3.95B | $4.06B | $5.54B | $6.29B | $7.02B | $4.89B | $5.12B | $6.92B | · | |
| Total Debt | $3.95B | $4.06B | $5.54B | $6.29B | $7.02B | $4.89B | $5.12B | · | · | |
| Retained Earnings | $1.67B | $2.20B | $1.49B | $1.17B | $484M | $-89M | $-204M | $-238M | · | |
| Treasury Stock | $76M | $0 | · | · | · | · | · | · | · | |
| AOCI | $-17M | $-184M | $-69M | $-100M | $-43M | $22M | $-86M | $-66M | $26M | |
| Stockholders' Equity | $5.57B | $5.96B | $5.25B | $4.86B | $4.20B | $2.67B | $2.46B | $-3.05B | $-2.62B | |
| Liabilities + Equity | $11.79B | $12.11B | $12.97B | $13.46B | $13.90B | $9.91B | $9.77B | $9.91B | · | |
| Shares Outstanding | 682,000,000 | 680,800,000 | 676,600,000 | 674,300,000 | 609,700,000 | 580,100,000 | 572,800,000 | 132,800,000 | · |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $410M | $406M | $402M | $406M | $379M | $395M | $399M | $405M | $99M | |
| Stock-based Comp | $46M | $47M | $40M | $46M | $51M | $44M | $68M | $18M | $48M | |
| Deferred Tax | $8M | $-47M | $-172M | $-69M | $-18M | $-88M | $-107M | $-104M | $-431M | |
| Amort. of Intangibles | $301M | $300M | $308M | $318M | $291M | $308M | $312M | $321M | $65M | |
| Restructuring | $30M | $83M | $26M | $4M | $5M | $12M | $24M | $81M | $30M | |
| Operating Cash Flow | $624M | $841M | $870M | $844M | $954M | $930M | $354M | $200M | $-168M | |
| CapEx | $129M | $149M | $146M | $133M | $111M | $62M | $52M | $38M | $25M | |
| Investing Cash Flow | $-130M | $439M | $-144M | $-110M | $-4.12B | $-59M | $-42M | $-23M | $-6.68B | |
| Debt Issued | $1.11B | $0 | $0 | $327M | $2.83B | $3.94B | $1M | $36M | $9.25B | |
| Net Debt Issued | $-319M | $-1.34B | $-846M | $-620M | $2.30B | $-423M | $-1.88B | · | · | |
| Stock Issued | · | · | $0 | $0 | $967M | $0 | $4.24B | · | · | |
| Stock Repurchased | $75M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $-75M | · | $0 | $0 | $967M | · | · | · | · | |
| Financing Cash Flow | $-409M | $-1.28B | $-844M | $-649M | $3.22B | $-783M | $-308M | $-170M | $6.96B | |
| Net Change in Cash | $104M | $-23M | $-109M | $70M | $38M | $100M | $2M | $-800.0K | $122M | |
| Taxes Paid | $145M | $248M | $224M | $257M | $145M | $43M | $112M | $66M | $32M | |
| Free Cash Flow | $495M | $692M | $724M | $710M | $842M | $868M | $302M | · | · | |
| Levered FCF | · | · | $501M | $496M | $677M | $292M | $-107M | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.6% | 33.6% | 33.9% | 34.6% | 33.9% | 32.5% | 31.8% | · | · | |
| Operating Margin | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% | 11.1% | 9.1% | · | · | |
| Net Margin | -8.1% | 10.5% | 4.6% | 9.1% | 7.8% | 1.8% | 0.63% | · | · | |
| Pretax Margin | -6.7% | 12.6% | 5.9% | 11.3% | 10.2% | 0.97% | 0.67% | · | · | |
| EBITDA Margin | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% | 11.1% | 9.1% | · | · | |
| ROA | -4.4% | 5.7% | 2.4% | 5.0% | 4.8% | 1.2% | 0.38% | · | · | |
| ROE | -8.9% | 12.4% | 6.2% | 14.5% | 13.8% | 4.5% | 1.6% | · | · | |
| ROIC | -3.1% | 9.0% | 5.1% | 8.2% | 6.6% | 17.5% | 6.8% | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.1 | 1.6 | 1.6 | 1.7 | 1.8 | 1.9 | · | · | |
| Quick Ratio | 1.0 | 0.6 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | · | · | |
| Debt / Equity | 0.7 | 0.7 | 1.1 | 1.3 | 1.7 | 1.8 | 2.1 | · | · | |
| LT Debt / Equity | 0.7 | 0.5 | 1.0 | 1.2 | 1.7 | 1.8 | 2.0 | · | · | |
| Interest Coverage | · | · | 2.4 | 4.3 | 4.5 | 2.3 | 1.3 | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | · | · | |
| Inventory Turnover | 5.7 | 5.8 | 5.3 | 5.5 | 6.1 | 5.9 | 6.0 | · | · | |
| Receivables Turnover | 6.2 | 6.2 | 5.9 | 6.2 | 6.3 | 6.1 | 6.3 | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.16 | $8.75 | $7.76 | $7.20 | $6.88 | $4.61 | $4.30 | · | · | |
| Revenue / Share | $9.63 | $9.95 | $10.27 | $11.06 | $12.32 | $10.96 | · | · | · | |
| Cash Flow / Share | $0.92 | $1.23 | $1.28 | $1.24 | $1.59 | $1.59 | · | · | · | |
| Cash / Share | $0.54 | $0.38 | $0.39 | $0.55 | $0.49 | $0.49 | $0.33 | · | · | |
| EPS (TTM) | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 | $0.09 | $-0.84 | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -3.4% | -2.6% | -7.3% | 1.7% | 15.5% | · | · | · | · | |
| Revenue CAGR 3Y | -4.5% | -2.8% | 2.9% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.49% | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 121.3% | -53.5% | 18.8% | 844.4% | · | · | · | · | |
| EPS CAGR 3Y | · | 7.0% | 73.5% | · | · | · | · | · | · | |
| Net Income YoY | · | 121.6% | -53.2% | 19.9% | 391.1% | · | · | · | · | |
| Net Income CAGR 3Y | · | 7.5% | 40.2% | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B | $6.39B | $6.04B | · | · | |
| Net Income TTM | $-530M | $712M | $321M | $686M | $573M | $117M | $38M | · | · | |
| Market Cap | $7.82B | $14.34B | $15.45B | $14.22B | $25.69B | $16.33B | $10.40B | · | · | |
| Enterprise Value | $11.40B | $18.14B | $20.72B | $20.14B | $32.41B | $20.94B | $15.33B | · | · | |
| P/E | -14.7 | 20.3 | 48.6 | 20.9 | 49.6 | 312.8 | -21.6 | · | · | |
| P/S | 1.2 | 2.1 | 2.2 | 1.9 | 3.5 | 2.6 | 1.7 | · | · | |
| P/B | 1.4 | 2.4 | 2.9 | 2.9 | 6.1 | 6.1 | 4.2 | · | · | |
| P / Cash Flow | 12.5 | 17.1 | 17.8 | 16.9 | 26.9 | 17.6 | 29.4 | · | · | |
| P / FCF | 15.8 | 20.7 | 21.3 | 20.0 | 30.5 | 18.8 | 34.4 | · | · | |
| EV / EBITDA | -46.3 | 16.7 | 29.8 | 17.8 | 33.3 | 29.6 | 27.8 | · | · | |
| EV / FCF | 23.0 | 26.2 | 28.6 | 28.4 | 38.5 | 24.1 | 50.7 | · | · | |
| EV / Revenue | 1.7 | 2.7 | 3.0 | 2.7 | 4.4 | 3.3 | 2.5 | · | · | |
| Earnings Yield | -6.8% | 4.9% | 2.1% | 4.8% | 2.0% | 0.32% | -4.6% | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.69B | $1.58B | $1.66B | $1.62B | $1.68B | $1.58B | $1.69B | $1.71B | $1.70B | $1.68B | $1.72B | $1.72B | $1.74B | $1.78B | $1.79B | $1.86B | |
| Cost of Revenue | $1.16B | $1.08B | $1.14B | $1.10B | $1.13B | $1.05B | $1.12B | $1.15B | $1.12B | $1.11B | $1.15B | $1.14B | $1.15B | $1.16B | $1.18B | $1.21B | |
| Gross Profit | $537M | $501M | $524M | $526M | $554M | $535M | $563M | $564M | $582M | $570M | $570M | $579M | $590M | $625M | $614M | $651M | |
| SG&A Expense | $415M | $401M | $392M | $390M | $425M | $388M | $371M | $440M | $406M | $424M | $387M | $368M | $358M | $394M | $363M | $375M | |
| Operating Income | $122M | $100M | $126M | $-649M | $129M | $147M | $638M | $125M | $176M | $146M | $183M | $210M | $72M | $231M | $252M | $276M | |
| Interest Expense | $39M | $43M | · | $44M | $43M | $42M | · | $49M | $61M | $64M | · | $72M | $73M | $74M | · | $67M | |
| Interest Income | $10M | $10M | $11M | $12M | $11M | $8M | $12M | $27M | $18M | $18M | $18M | $17M | $16M | $14M | · | · | |
| Other Non-op | $-600.0K | $-500.0K | $-1M | $4M | $-4M | $-20M | $-5M | $700.0K | $2M | $1M | $2M | $700.0K | $2M | $600.0K | $-6M | $3M | |
| Pretax Income | $81M | $56M | $81M | $-690M | $82M | $86M | $584M | $74M | $115M | $81M | $120M | $136M | $-1M | $156M | $175M | $208M | |
| Income Tax | $43M | $12M | $28M | $22M | $17M | $21M | $84M | $17M | $22M | $20M | $21M | $28M | $6M | $34M | $33M | $41M | |
| Net Income | $38M | $43M | $52M | $-712M | $65M | $64M | $500M | $58M | $93M | $60M | $98M | $108M | $-7M | $122M | $142M | $167M | |
| EPS (Basic) | $0.06 | $0.06 | $0.08 | $-1.04 | $0.09 | $0.09 | $0.74 | $0.08 | $0.14 | $0.09 | $0.15 | $0.16 | $-0.01 | $0.18 | $0.20 | $0.25 | |
| EPS (Diluted) | $0.06 | $0.06 | $0.08 | $-1.04 | $0.09 | $0.09 | $0.73 | $0.08 | $0.14 | $0.09 | $0.14 | $0.16 | $-0.01 | $0.18 | $0.20 | $0.25 | |
| Shares (Basic) | 676,200,000 | 675,700,000 | · | 681,700,000 | 681,500,000 | 681,100,000 | · | 680,300,000 | 679,400,000 | 678,100,000 | · | 676,000,000 | 675,300,000 | 674,700,000 | · | 674,100,000 | |
| Shares (Diluted) | 677,200,000 | 676,800,000 | · | 681,700,000 | 681,800,000 | 682,400,000 | · | 683,000,000 | 682,600,000 | 681,400,000 | · | 678,500,000 | 675,300,000 | 678,100,000 | · | 679,300,000 | |
| EBITDA | $122M | $100M | · | $-649M | $129M | $147M | · | $125M | $176M | $146M | · | $210M | $72M | $231M | · | $276M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $307M | $279M | $365M | $252M | $449M | $316M | $262M | $285M | $273M | $235M | · | $237M | $236M | $295M | · | $266M | |
| Receivables | $1.14B | $1.10B | $1.07B | $1.08B | $1.15B | $1.10B | $1.03B | $1.09B | $1.13B | $1.13B | · | $1.15B | $1.22B | $1.28B | · | $1.23B | |
| Inventory | $829M | $810M | $818M | $796M | $780M | $750M | $732M | $780M | $796M | $811M | · | $850M | $890M | $904M | · | $905M | |
| Other Current Assets | $188M | $210M | $193M | $132M | $136M | $120M | $119M | $136M | $132M | $146M | · | $147M | $156M | $152M | · | $158M | |
| Current Assets | $2.46B | $2.40B | $2.45B | $2.26B | $2.51B | $2.28B | $2.15B | $2.50B | $2.33B | $2.32B | · | $2.38B | $2.50B | $2.63B | · | $2.56B | |
| PP&E (Net) | $772M | $766M | $767M | $762M | $759M | $736M | $708M | $723M | $754M | $740M | · | $698M | $698M | $736M | · | $698M | |
| PP&E (Gross) | · | · | $1.51B | · | · | · | $1.34B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $787M | $766M | $745M | $724M | $700M | $663M | $630M | $621M | $657M | $635M | · | $580M | $565M | $541M | · | $489M | |
| Goodwill | $4.94B | $4.95B | $4.99B | $4.98B | $5.76B | $5.61B | $5.54B | $5.67B | $5.66B | $5.67B | $5.72B | $5.64B | $5.69B | $5.68B | $5.65B | $5.51B | |
| Intangibles | $2.92B | $3.01B | $3.10B | $3.17B | $3.26B | $3.24B | $3.27B | $3.43B | $3.49B | $3.57B | · | $3.70B | $3.80B | $3.98B | · | $4.01B | |
| Other Non-current Assets | $412M | $442M | $396M | $406M | $391M | $368M | $360M | $420M | $368M | $368M | · | $289M | $277M | $272M | · | $245M | |
| Total Assets | $11.60B | $11.66B | $11.79B | $11.68B | $12.78B | $12.33B | $12.11B | $12.84B | $12.69B | $12.76B | · | $12.80B | $13.06B | $13.40B | · | $13.11B | |
| Accounts Payable | $743M | $736M | $742M | $692M | $709M | $680M | $663M | $674M | $657M | $573M | · | $656M | $687M | $766M | · | $769M | |
| Current Liabilities | $1.38B | $1.37B | $1.38B | $1.52B | $2.58B | $2.03B | $2.01B | $1.63B | $1.46B | $1.44B | · | $1.49B | $1.55B | $1.67B | · | $1.55B | |
| Capital Leases | · | · | $152M | · | · | · | $143M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $540M | $550M | $557M | $548M | $536M | $550M | $557M | $547M | $575M | $601M | · | $649M | $663M | $696M | · | $728M | |
| Other Non-current Liabilities | $383M | $377M | $378M | $403M | $391M | $365M | $358M | $419M | $362M | $361M | · | $271M | $269M | $300M | · | $334M | |
| Total Liabilities | $5.97B | $6.07B | $6.23B | $6.11B | $6.49B | $6.23B | $6.16B | $7.29B | $7.26B | $7.43B | · | $7.70B | $8.05B | $8.40B | · | $8.52B | |
| Long-term Debt | $3.70B | $3.82B | $3.95B | $3.86B | $4.24B | $4.11B | $4.06B | $4.92B | $5.12B | $5.32B | · | $5.63B | $5.88B | $6.06B | · | $6.19B | |
| Total Debt | $3.70B | $3.82B | · | $3.86B | $4.24B | $4.11B | · | $4.92B | $5.12B | $5.32B | · | $5.63B | $5.88B | $6.06B | · | $6.19B | |
| Retained Earnings | $1.75B | $1.72B | $1.67B | $1.62B | $2.33B | $2.27B | $2.20B | $1.70B | $1.64B | $1.55B | · | $1.39B | $1.28B | $1.29B | · | $1.03B | |
| Treasury Stock | $76M | $76M | $76M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $-55M | $-44M | $-17M | $-24M | $-10M | $-118M | $-184M | $-74M | $-107M | $-97M | · | $-111M | $-72M | $-90M | $-100M | $-212M | |
| Stockholders' Equity | $5.63B | $5.59B | $5.57B | $5.57B | $6.29B | $6.10B | $5.96B | $5.55B | $5.43B | $5.34B | $5.25B | $5.10B | $5.01B | $4.99B | $4.86B | $4.59B | |
| Liabilities + Equity | $11.60B | $11.66B | $11.79B | $11.68B | $12.78B | $12.33B | $12.11B | $12.84B | $12.69B | $12.76B | · | $12.80B | $13.06B | $13.40B | · | $13.11B | |
| Shares Outstanding | · | 682,900,000 | 682,000,000 | 681,900,000 | 681,600,000 | 681,500,000 | 680,800,000 | 680,600,000 | 679,600,000 | 679,200,000 | · | 676,300,000 | 675,700,000 | 675,100,000 | · | 674,200,000 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $106M | $105M | $103M | $104M | $103M | $100M | $101M | $102M | $103M | $100M | $101M | $98M | $103M | $101M | $101M | $101M | |
| Stock-based Comp | $15M | $9M | $11M | $7M | $16M | $12M | $11M | $12M | $11M | $13M | $9M | $10M | $9M | $13M | $10M | $12M | |
| Deferred Tax | $16M | $-10M | $50M | $-12M | $-18M | $-12M | $28M | $-23M | $-35M | $-18M | $-78M | $-29M | $-38M | $-26M | $-7M | $-22M | |
| Restructuring | · | · | $2M | $2M | · | · | $500.0K | $49M | · | · | $8M | $6M | $7M | $5M | $-200.0K | $1M | |
| Operating Cash Flow | $178M | $59M | $153M | $207M | $154M | $109M | $173M | $245M | $281M | $142M | $252M | $231M | $168M | $220M | $206M | $258M | |
| CapEx | $38M | $34M | $36M | $36M | $30M | $28M | $28M | $41M | $46M | $35M | $51M | $38M | $30M | $28M | $34M | $39M | |
| Investing Cash Flow | $-37M | $-33M | $-40M | $-33M | $-29M | $-29M | $558M | $-40M | $-45M | $-34M | $-50M | $-37M | $-29M | $-27M | $-33M | $4M | |
| Debt Issued | · | · | $1.04B | $68M | $0 | $0 | $0 | $-12M | $-29M | $41M | $0 | $0 | $0 | $0 | $82M | $35M | |
| Net Debt Issued | · | $-105M | · | · | · | $-31M | · | · | · | $-169M | · | · | · | $-270M | · | · | |
| Financing Cash Flow | $-112M | $-107M | $700.0K | $-370M | $-7M | $-34M | $-755M | $-199M | $-197M | $-130M | $-184M | $-188M | $-196M | $-275M | $-82M | $-219M | |
| Net Change in Cash | $28M | $-86M | $114M | $-198M | $134M | $54M | $-46M | $14M | $38M | $-28M | $27M | $-100.0K | $-58M | $-78M | $109M | $27M | |
| Taxes Paid | $30M | $10M | $29M | $22M | $77M | $17M | $120M | $42M | $69M | $17M | $29M | $69M | $113M | $14M | $75M | $51M | |
| Free Cash Flow | · | $25M | · | · | · | $81M | · | · | · | $107M | · | · | · | $192M | · | · | |
| Levered FCF | · | $-8M | · | · | · | $50M | · | · | · | $59M | · | · | · | $134M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.7% | 31.7% | · | 32.4% | 32.9% | 33.8% | · | 32.9% | 34.2% | 34.0% | · | 33.6% | 33.8% | 35.1% | · | 35.0% | |
| Operating Margin | 7.2% | 6.3% | · | -40.0% | 7.6% | 9.3% | · | 7.3% | 10.3% | 8.7% | · | 12.2% | 4.1% | 13.0% | · | 14.9% | |
| Net Margin | 2.2% | 2.7% | · | -43.8% | 3.8% | 4.1% | · | 3.4% | 5.5% | 3.6% | · | 6.3% | -0.42% | 6.8% | · | 9.0% | |
| Pretax Margin | 4.8% | 3.5% | · | -42.5% | 4.9% | 5.4% | · | 4.3% | 6.7% | 4.8% | · | 7.9% | -0.07% | 8.8% | · | 11.2% | |
| EBITDA Margin | 7.2% | 6.3% | · | -40.0% | 7.6% | 9.3% | · | 7.3% | 10.3% | 8.7% | · | 12.2% | 4.1% | 13.0% | · | 14.9% | |
| ROA | 0.31% | 0.36% | · | -5.8% | 0.51% | 0.51% | · | 0.45% | 0.72% | 0.46% | · | 0.84% | -0.06% | 0.89% | · | 1.3% | |
| ROE | 0.64% | 0.74% | · | -12.8% | 1.1% | 1.1% | · | 1.1% | 1.8% | 1.2% | · | 2.2% | -0.15% | 2.6% | · | 3.8% | |
| ROIC | 0.61% | 0.83% | · | -7.1% | 0.97% | 1.1% | · | 0.92% | 1.4% | 1.0% | · | 1.6% | 3.7% | 1.6% | · | 2.1% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.8 | · | 1.5 | 1.0 | 1.1 | · | 1.5 | 1.6 | 1.6 | · | 1.6 | 1.6 | 1.6 | · | 1.6 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.6 | 0.7 | · | 0.8 | 1.0 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.5 | 0.5 | · | 0.8 | 0.9 | 0.9 | · | 1.0 | 1.1 | 1.1 | · | 1.3 | |
| Interest Coverage | 3.1 | 2.3 | · | -14.7 | 3.0 | 3.5 | · | 2.6 | 2.9 | 2.3 | · | 2.9 | 1.0 | 3.1 | · | 4.1 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.4 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.5 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $8.18 | · | $8.17 | $9.22 | $8.95 | · | $8.16 | $8.00 | $7.86 | · | $7.54 | $7.42 | $7.40 | · | $6.81 | |
| Revenue / Share | $2.50 | $2.34 | · | $2.38 | $2.47 | $2.32 | · | $2.51 | $2.49 | $2.47 | · | $2.54 | $2.58 | $2.63 | · | $2.73 | |
| Cash Flow / Share | · | $0.09 | · | · | · | $0.16 | · | · | · | $0.21 | · | · | · | $0.32 | · | · | |
| Cash / Share | · | $0.41 | · | $0.37 | $0.66 | $0.46 | · | $0.42 | $0.40 | $0.35 | · | $0.35 | $0.35 | $0.44 | · | $0.39 | |
| EPS (TTM) | $-0.84 | $-0.81 | · | $-0.13 | $0.99 | $1.04 | · | $0.45 | $0.53 | $0.38 | · | $0.53 | $0.62 | $0.91 | · | $0.93 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.56B | $6.55B | · | $6.58B | $6.67B | $6.69B | · | $6.82B | $6.83B | $6.87B | · | $7.04B | $7.18B | $7.34B | · | $7.62B | |
| Net Income TTM | $-578M | $-551M | · | $-82M | $687M | $716M | · | $310M | $360M | $260M | · | $364M | $423M | $618M | · | $639M | |
| Market Cap | · | $5.35B | · | $8.51B | $9.17B | $11.05B | · | $17.61B | $14.41B | $17.37B | · | $14.26B | $13.88B | $14.27B | · | $13.21B | |
| Enterprise Value | · | $8.89B | · | $12.12B | $12.97B | $14.84B | · | $22.24B | $19.25B | $22.46B | · | $19.65B | $19.53B | $20.04B | · | $19.14B | |
| P/E | -11.8 | -9.7 | · | -96.0 | 13.6 | 15.6 | · | 57.5 | 40.0 | 67.3 | · | 39.8 | 33.1 | 23.2 | · | 21.1 | |
| P/S | · | 0.8 | · | 1.3 | 1.4 | 1.7 | · | 2.6 | 2.1 | 2.5 | · | 2.0 | 1.9 | 1.9 | · | 1.7 | |
| P/B | · | 1.0 | · | 1.5 | 1.5 | 1.8 | · | 3.2 | 2.7 | 3.3 | · | 2.8 | 2.8 | 2.9 | · | 2.9 | |
| P / Cash Flow | · | 91.2 | · | · | · | 101.1 | · | · | · | 122.6 | · | · | · | 65.0 | · | · | |
| EV / Revenue | · | 1.4 | · | 1.8 | 1.9 | 2.2 | · | 3.3 | 2.8 | 3.3 | · | 2.8 | 2.7 | 2.7 | · | 2.5 | |
| Earnings Yield | -8.5% | -10.3% | · | -1.0% | 7.4% | 6.4% | · | 1.7% | 2.5% | 1.5% | · | 2.5% | 3.0% | 4.3% | · | 4.7% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B |
| Brüt Kâr Marjı % | 32.6% | 33.6% | 33.9% | 34.6% | 33.9% |
| Faaliyet Kâr Marjı % | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% |
| Net Gelir | $-530M | $712M | $321M | $686M | $573M |
| Seyreltilmiş Hisse Başı Kâr | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.7 | 0.7 | 1.1 | 1.3 | 1.7 |
| Cari Oran | 1.8 | 1.1 | 1.6 | 1.6 | 1.7 |
| Cari Oran | 1.0 | 0.6 | 1.0 | 1.0 | 1.1 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $495M | $692M | $724M | $710M | $842M |
Kurumsal Sahipler (13F) 493 dosya · $7.6B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
493
Tutulan Değer
$7.6B
Yeni pozisyonlar
97
Çıkan pozisyonlar
60
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 97 (-7 önceki Ç'ye göre) | 60 (-11 önceki Ç'ye göre) | 192 (+31 önceki Ç'ye göre) | 113 (-15 önceki Ç'ye göre) | +24.9M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Dodge & Cox | $1.188.207.643 | 120.020.974 | 15,59% | Hisse senetleri |
| VANGUARD GROUP INC | $743.810.028 | 64.904.889 | 9,76% | Hisse senetleri |
| BlackRock, Inc. | $695.784.194 | 70.281.231 | 9,13% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $310.298.175 | 31.343.250 | 4,07% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $304.948.067 | 30.802.835 | 4,00% | Hisse senetleri |
| GREENHAVEN ASSOCIATES INC | $243.909.369 | 24.637.310 | 3,20% | Hisse senetleri |
| STATE STREET CORP | $213.572.443 | 21.572.974 | 2,80% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $202.086.268 | 20.412.181 | 2,65% | Hisse senetleri |
| Engine Capital Management, LP | $196.622.217 | 19.860.830 | 2,58% | Hisse senetleri |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $195.386.083 | 19.735.968 | 2,56% | Hisse senetleri |
| New Mountain Capital, L.L.C. | $138.600.000 | 14.000.000 | 1,82% | Hisse senetleri |
| Invesco Ltd. | $137.465.065 | 13.885.360 | 1,80% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $130.519.321 | 13.180.567 | 1,71% | Hisse senetleri |
| MARSHALL WACE, LLP | $129.988.565 | 13.130.158 | 1,71% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $115.112.902 | 11.627.566 | 1,51% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $108.794.506 | 10.989.344 | 1,43% | Hisse senetleri |
| EARNEST PARTNERS LLC | $106.410.397 | 10.748.525 | 1,40% | Hisse senetleri |
| LONDON CO OF VIRGINIA | $103.811.008 | 10.485.960 | 1,36% | Hisse senetleri |
| FULLER & THALER ASSET MANAGEMENT, INC. | $101.537.816 | 10.256.345 | 1,33% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $94.758.077 | 9.571.523 | 1,24% | Hisse senetleri |
| First Pacific Advisors, LP | $81.088.326 | 8.190.740 | 1,06% | Hisse senetleri |
| SEI INVESTMENTS CO | $78.677.367 | 7.947.198 | 1,03% | Hisse senetleri |
| FMR LLC | $77.670.074 | 7.845.462 | 1,02% | Hisse senetleri |
| GENDELL JEFFREY L | $75.311.973 | 7.607.270 | 0,99% | Hisse senetleri |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | $73.188.967 | 7.392.825 | 0,96% | Hisse senetleri |
| Clarkston Capital Partners, LLC | $67.214.209 | 6.789.314 | 0,88% | Hisse senetleri |
| MORGAN STANLEY | $66.905.804 | 6.758.161 | 0,88% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $61.422.976 | 6.204.341 | 0,81% | Hisse senetleri |
| NORGES BANK | $60.307.949 | 6.091.712 | 0,79% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $57.627.950 | 5.821.005 | 0,76% | Hisse senetleri |
| NORTHERN TRUST CORP | $56.753.512 | 5.732.678 | 0,74% | Hisse senetleri |
| Freestone Grove Partners LP | $56.577.352 | 5.714.884 | 0,74% | Hisse senetleri |
| UBS Group AG | $56.155.742 | 5.672.297 | 0,74% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $54.696.928 | 5.524.942 | 0,72% | Hisse senetleri |
| YACKTMAN ASSET MANAGEMENT LP | $47.223.000 | 4.770.000 | 0,62% | Hisse senetleri |
| SOUTHEASTERN ASSET MANAGEMENT INC/TN/ | $46.782.232 | 4.725.478 | 0,61% | Hisse senetleri |
| Brickwood Asset Management LLP | $45.515.438 | 4.597.519 | 0,60% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $42.790.226 | 4.322.245 | 0,56% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $42.363.659 | 4.120.981 | 0,56% | Hisse senetleri |
| Bank of New York Mellon Corp | $40.800.098 | 4.121.222 | 0,54% | Hisse senetleri |
| ROYCE & ASSOCIATES LP | $36.393.232 | 3.676.084 | 0,48% | Hisse senetleri |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $34.719.001 | 3.506.970 | 0,46% | Hisse senetleri |
| PRIVATE MANAGEMENT GROUP INC | $30.662.617 | 3.097.234 | 0,40% | Hisse senetleri |
| Voss Capital, LP | $26.235.000 | 2.650.000 | 0,34% | Hisse senetleri |
| Prescott General Partners LLC | $25.740.000 | 2.600.000 | 0,34% | Hisse senetleri |
| Gotham Asset Management, LLC | $24.912.796 | 2.516.444 | 0,33% | Hisse senetleri |
| Quantinno Capital Management LP | $24.177.175 | 2.442.138 | 0,32% | Hisse senetleri |
| KINNEY ASSET MANAGEMENT, LLC | $23.025.600 | 1.845.000 | 0,30% | Hisse senetleri |
| Loews Corp | $21.780.000 | 2.200.000 | 0,29% | Hisse senetleri |
| Western Standard LLC | $20.888.842 | 2.109.984 | 0,27% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| The Goldman Sachs Group, Inc., Goldman Sachs & Co. LLC, Broad Street Principal Investments, L.L.C., Bridge Street Opportunity Advisors, L.L.C., StoneBridge 2017, L.P., StoneBridge 2017 Offshore, L.P., StoneBridge 2018, L.P., StoneBridge 2018 Offshore, L.P., VWR Partners, L.P. ×8 başvurular | 07 Mayıs 2021 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 47 içeriden öğrenenler · 29 yöneticiler · 20 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Emmanuel Ligner | President and CEO | 18 Ağustos 2026 F | 737.334 | 1 | 0 | $993.125 |
| Michael Stubblefield | President & CEO | 21 Mayıs 2025 G | 545.500 | 0 | 0 | $0 |
| Todd W. Garner | EVP and CFO | 21 Eylül 2026 A | 49.688 | 0 | 0 | $0 |
| Brent R. Jones | EVP, Chief Financial Officer | 23 Şubat 2026 F | 419.782 | 0 | 0 | $0 |
| Thomas A Szlosek | EVP & CFO | 17 Mayıs 2023 F | 77.489 | 0 | 0 | $0 |
| Corey Walker | President, VWR Dist. & Servs. | 21 Haziran 2026 F | 384.535 | 0 | 0 | $0 |
| Mary Blenn | EVP, Chief Operating Officer | 19 Şubat 2026 A | 253.384 | 0 | 0 | $0 |
| Bjorn Hofman | EVP and COO | 21 Mayıs 2019 A | 157.143 | 0 | 0 | $0 |
| Brittany Hankamer | EVP, Chief HR Officer | 14 Ağustos 2026 F | 248.864 | 0 | 0 | $0 |
| Steven W Eck | SVP & Chief Accounting Officer | 31 Temmuz 2026 F | 129.593 | 0 | 0 | $0 |
| Claudius Sokenu | EVP, Chief Legal & Compliance | 24 Temmuz 2026 F | 251.228 | 0 | 0 | $0 |
| Ludovic Brellier | EVP, Bioscience & Medtech | 01 Mayıs 2026 A | 146.566 | 0 | 0 | $0 |
| Benoit Gourdier | EVP, Bioscience & Medtech | 23 Şubat 2026 F | 362.859 | 0 | 0 | $0 |
| Christophe Couturier | EVP, AMEA | 08 Ağustos 2025 A | 211.271 | 0 | 0 | $0 |
| James Bramwell | EVP Sales, Customer Excellence | 27 Şubat 2025 S | 86.605 | 0 | 0 | $0 |
| Kitty Sahin | EVP, Strategy&Corp Development | 18 Temmuz 2024 F | 42.274 | 0 | 0 | $0 |
| Randy Lee Stone | EVP, Laboratory Solutions | 16 Nisan 2024 F | 68.105 | 0 | 0 | $0 |
| Sheri Lewis | EVP, Global Ops & Supply Chain | 31 Aralık 2023 F | 70.692 | 0 | 0 | $0 |
| Frederic Vanderhaegen | EVP, Americas and Europe | 25 Ağustos 2023 S | 160.735 | 0 | 0 | $0 |
| Justin Miller | EVP & General Counsel | 17 Mayıs 2023 F | 93.336 | 0 | 0 | $0 |
| Gerard Brophy | EVP, Biopharma Production | 17 Mayıs 2023 F | 89.032 | 0 | 0 | $0 |
| Meghan Henson | EVP, Chief HR Officer | 24 Şubat 2023 A | 40.184 | 0 | 0 | $0 |
| Michael Wondrasch | EVP & CIO | 20 Şubat 2023 F | 96.072 | 0 | 0 | $0 |
| Mark Christopher Murray | EVP, Biomaterials & AT | 13 Ocak 2022 F | 18.680 | 0 | 0 | $0 |
| Devashish Ohri | EVP, IMEA | 27 Mayıs 2021 M | 139.095 | 0 | 0 | $0 |
| Sven Henrichwark | EVP, APAC Region | 25 Şubat 2021 A | 19.802 | 0 | 0 | $0 |
| Eric Mcallister | EVP, CHRO | 17 Mayıs 2020 F | 197.899 | 0 | 0 | $0 |
| Tanya Foxe | EVP, Operations & Supply Chain | 21 Şubat 2020 A | 39.458 | 0 | 0 | $0 |
| Ashish Kulkarni | EVP and Chief Technology Officer | 21 Mayıs 2019 A | 128.571 | 0 | 0 | $0 |
| Gregory T Lucier | Yönetim kurulu üyesi | 08 Mayıs 2026 P | 60.000 | 2 | 0 | $541.200 |
| Simon Dingemans | Yönetim kurulu üyesi | 07 Mayıs 2026 A | 31.495 | 1 | 0 | $203.500 |
| Louise Makin | Yönetim kurulu üyesi | 07 Mayıs 2026 A | 47.140 | 0 | 0 | $0 |
| Mala Murthy | Yönetim kurulu üyesi | 07 Mayıs 2026 A | 69.479 | 0 | 0 | $0 |
| Michael Severino | Yönetim kurulu üyesi | 07 Mayıs 2026 A | 85.821 | 0 | 0 | $0 |
| Joseph R Massaro | Yönetim kurulu üyesi | 07 Mayıs 2026 A | 77.408 | 0 | 0 | $0 |
| Gregory L Summe | Yönetim kurulu üyesi | 07 Mayıs 2026 A | 83.381 | 2 | 0 | $2.065.000 |
| Sanjeev K Mehra | Yönetim kurulu üyesi | 07 Mayıs 2026 A | 33.376 | 2 | 0 | $4.882.750 |
| John Carethers | Yönetim kurulu üyesi | 08 Mayıs 2025 A | 45.858 | 0 | 0 | $0 |
| Lan Kang | Yönetim kurulu üyesi | 08 Mayıs 2025 A | 52.315 | 0 | 0 | $0 |
| Juan Andres | Yönetim kurulu üyesi | 08 Mayıs 2025 A | 65.480 | 0 | 0 | $0 |
| Jonathan M Peacock | Yönetim kurulu üyesi | 08 Mayıs 2025 A | 219.815 | 0 | 0 | $0 |
| Christi Shaw | Yönetim kurulu üyesi | 11 Mayıs 2023 A | 36.271 | 0 | 0 | $0 |
| Matthew S. Holt | Yönetim kurulu üyesi | 12 Mayıs 2022 A | 7.908 | 0 | 0 | $0 |
| Rajiv Gupta | Yönetim kurulu üyesi | 01 Nisan 2022 A | 780.562 | 0 | 0 | $0 |
| Jo Natauri | Yönetim kurulu üyesi | 12 Temmuz 2021 P | 557.656 | 0 | 0 | $0 |
| Rakesh Sachdev | Yönetim kurulu üyesi | 25 Şubat 2021 A | 32.841 | 0 | 0 | $0 |
| Thomas Connolly | Yönetim kurulu üyesi | 18 Haziran 2020 S | 72.620.082 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 56 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| LSEQ · Harbor ETF Trust | 2,52% | 27.960 NS | 31 Temmuz 2026 | N-PORT |
| EPSB · Harbor ETF Trust | 1,77% | 6.133 NS | 31 Temmuz 2026 | N-PORT |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 1,51% | 11.851.000 | 02 Ekim 2026 | Günlük |
| DFSV · Dimensional ETF Trust | 0,52% | 3.118.943 NS | 31 Temmuz 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,40% | 25.471 NS | 31 Temmuz 2026 | N-PORT |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,39% | 586.296 SH | 19 Ağustos 2026 | Günlük |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,32% | 88.836 SH | 02 Ekim 2026 | Günlük |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,27% | 230.747 SH | 02 Ekim 2026 | Günlük |
| VFVA · VANGUARD WELLINGTON FUND | 0,27% | 233.604 SH | 19 Ağustos 2026 | Günlük |
| PTMC · Pacer Funds Trust | 0,27% | 75.616 NS | 31 Temmuz 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,20% | 188.520 NS | 31 Temmuz 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,20% | 10.027 NS | 31 Temmuz 2026 | N-PORT |
| ESML · iShares Trust | 0,20% | 376.218 SH | 11 Eylül 2026 | Günlük |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 286.321 NS | 31 Temmuz 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,19% | 1.104.592 SH | 19 Ağustos 2026 | Günlük |
| DFAT · Dimensional ETF Trust | 0,17% | 1.765.932 NS | 31 Temmuz 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,17% | 1.854.609 NS | 31 Temmuz 2026 | N-PORT |
| IYH · iShares Trust | 0,16% | 386.410 SH | 11 Eylül 2026 | Günlük |
| VBR · VANGUARD INDEX FUNDS | 0,14% | 9.920.672 SH | 19 Ağustos 2026 | Günlük |
| SMMD · iShares Trust | 0,14% | 351.599 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,13% | 313.238 NS | 31 Temmuz 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,12% | 28.653 NS | 31 Temmuz 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,10% | 1.983.361 SH | 19 Ağustos 2026 | Günlük |
| IWS · iShares Trust | 0,10% | 978.878 SH | 11 Eylül 2026 | Günlük |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 50.803 SH | 02 Ekim 2026 | Günlük |
| WSML · iShares Trust | 0,09% | 41.659 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,08% | 7.835.858 SH | 19 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,08% | 15.636.784 SH | 19 Ağustos 2026 | Günlük |
| TILT · FlexShares Trust | 0,08% | 121.976 NS | 31 Temmuz 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,08% | 325.274 NS | 31 Temmuz 2026 | N-PORT |
| IWR · iShares Trust | 0,07% | 2.700.866 SH | 11 Eylül 2026 | Günlük |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 37.709 SH | 02 Ekim 2026 | Günlük |
| PRF · Invesco Exchange-Traded Fund Trust | 0,04% | 251.941 SH | 02 Ekim 2026 | Günlük |
| IUSV · iShares Trust | 0,03% | 593.664 SH | 11 Eylül 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,03% | 11.452 NS | 31 Temmuz 2026 | N-PORT |
| IWD · iShares Trust | 0,03% | 1.462.438 SH | 11 Eylül 2026 | Günlük |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 397.791 SH | 19 Ağustos 2026 | Günlük |
| IYY · iShares Trust | 0,01% | 29.349 SH | 11 Eylül 2026 | Günlük |
| IWB · iShares Trust | 0,01% | 457.613 SH | 11 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,01% | 885.606 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,01% | 183.968 SH | 11 Eylül 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 21.681.946 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 534.809 SH | 19 Ağustos 2026 | Günlük |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 109.164 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 55.632 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,01% | 149.286 SH | 19 Ağustos 2026 | Günlük |
| NEAR · iShares U.S. ETF Trust | 0,01% | 365.000 SH | 09 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,00% | 5.257 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 544 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 1.476 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 2.958 NS | 31 Temmuz 2026 | N-PORT |
| IJH · iShares Trust | · | 23.957.709 SH | 11 Eylül 2026 | Günlük |
| IJJ · iShares Trust | · | 3.487.441 SH | 31 Ağustos 2026 | Günlük |
| XJH · iShares Trust | · | 93.400 SH | 08 Eylül 2026 | Günlük |
| ISCB · iShares Trust | · | 29.420 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 144.718 SH | 11 Eylül 2026 | Günlük |
AVTR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 25 analist
TUT
Medyan hedef
$14.20
-10,2%
3 12,0%
Güçlü Al
5 20,0%
Al
16 64,0%
Tut
1 4,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
14 analist · 2026-10-05Ortalama hedef $14.56 -7,9%
Şimdi
Mevcut fiyat $15.81
Düşük$12.00
Ortalama$14.56
Yüksek$19.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| AVTR | $7.82B | -14.7 | -3.4% | -8.1% | -8.9% | 32.6% |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | · |
| TXG | $2.08B | -46.6 | 5.2% | -6.8% | -5.5% | 69.0% |
| TECH | $11.03B | 60.9 | -0.38% | 15.0% | 9.0% | 65.8% |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | · |
| BIO | · | · | · | · | · | · |
| BRKR | $7.17B | -314.1 | 2.1% | -0.25% | -0.40% | 45.9% |
| SHC | $5.02B | 65.3 | 5.7% | 6.7% | 14.0% | 55.5% |
| ADPT | $2.50B | -41.6 | 54.8% | -21.5% | -28.2% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Tem 29, 2026